Clinical Trial Update: Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study evaluating immunologic response to Kansui in treated HIV+ individuals; the study is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Kansui (Kansui)

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV, Human Immunodeficiency Virus | Phase 1 | Status: TERMINATED | Results posted: 2024-04-19